Pharmafile Logo
Pharmafocus logo
Advanced Search
800px-thumbnail

COVID-19 patients are experiencing long-term effects from the virus

August 13, 2020
COVID, COVID-19, coronavirus

Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.

News

FDA approves NS Pharma’s Viltepso for Duchenne muscular dystrophy, but concerns over benefit persist

August 13, 2020
Sales and Marketing Duchenne Muscular Dystrophy, FDA, NS pharma, Viltepso

NS Pharma has claimed a tentative FDA approval for its Viltepso (viltolarsen) injection in the treatment of Duchenne muscular dystrophy …

News
fake_news

Coronavirus fake news has led to hundreds of deaths, according to a new study

August 13, 2020
Medical Communications COVID, coronavirus, fake news

At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …

News
shutterstock_158366573

Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues

August 12, 2020
Research and Development COVID-19, Gilead, pharma, remdesivir

New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …

News
bristol_myers_squibb

Bristol Myers Squibb announces positive results from Opdivo clinical trials

August 12, 2020
Research and Development Bristol-Myers Squibb, Cancer, bristol myers squibb

Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo. The first trial …

News
giant-mexican-flag-waves

Mexico to hold trials for Chinese and American COVID-19 vaccines

August 12, 2020
Research and Development COVID-19, Mexico, Mexico coronavirus

Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope …

News
moderna

Moderna commits 100 million COVID-19 vaccine doses to the US

August 12, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, US, Vaccine, pharma

Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …

News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

August 12, 2020
Research and Development COVID-19, coronavirus, covid news

The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …

News
shutterstock_273326141

Bayer scoops up women’s healthcare biotech KaNDy Therapeutics in potential $1bn+ deal

August 11, 2020
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, KaNDy Therapeutics, menopause, pharma

Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced …

News
roche

Roche’s entrolizumab disappoints at Phase 3 in moderately to severely active ulcerative colitis

August 11, 2020
Manufacturing and Production, Research and Development Roche, etrolizumab, trial failure, ulcerative colitis

Roche has voiced its disappointment after its investigational therapy etrolizumab showed “mixed results” as a treatment for moderately to severely …

News
fda

Gilead applies for FDA approval to treat coronavirus patients with remdesivir

August 11, 2020
Manufacturing and Production COVID-19, Gilead, coronavirus

Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients. The drug would go under …

News
gestational_diabetes_kit

Arthritis drug Abatacept could be used to treat type 1 diabetes

August 11, 2020
Manufacturing and Production diabetes, insulin, tye 1, type 2

People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds. Researchers at …

News
vxxxxeer

Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine

August 11, 2020
Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus

President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …

News
christine

Dr Christine Wilkinson Blanc appointed as Chief Medical Officer at Nordic Nanovector

August 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has announced that Dr Christine Wilkinson Blanc has been appointed as the Chief Medical Officer of the company.

Appointment
droxtchcc

Over 100 Americans have died after taking hydroxychloroquine in the first half of 2020

August 10, 2020
Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine

More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus. This was found in …

News
vxxxxeer

Over a third of Americans say they won’t take a coronavirus vaccine

August 10, 2020
Sales and Marketing COVID-19, coronavirus, vaccines

35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling. A new Gallup …

News
novavax

Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions

August 10, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine

Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …

News
fda

FDA approves opioid Olinvyk for patients with acute pain

August 10, 2020
Sales and Marketing opioid crisis, opioids

The FDA has approved Olinvyk for the management of moderate to severe pain in adult patients when their pain is …

News
fdaoutsideweb

Genentech’s Evrysdi becomes first FDA-approved oral treatment for spinal muscular atrophy

August 10, 2020
Sales and Marketing Evrysdi, FDA, Genentech, Roche, spinal muscular atrophy

Genentech’s Evrysdi (risdiplam) has secured FDA approval for the treatment of spinal muscular atrophy (SMA), making it the first oral therapy …

News
vaccination-1215279_960_720

Early promise from Novavax’s vaccine candidate for COVID-19

August 7, 2020
Medical Communications, Research and Development COVID-19, Novavax, Vaccine

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025